Drug information for SLO-BID

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL 100MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 87892
CAPSULE, EXTENDED RELEASE; ORAL 200MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 87893
CAPSULE, EXTENDED RELEASE; ORAL 300MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 87894
CAPSULE, EXTENDED RELEASE; ORAL 50MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 88269
CAPSULE, EXTENDED RELEASE; ORAL 75MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 89539
CAPSULE, EXTENDED RELEASE; ORAL 125MG Discontinued   THEOPHYLLINE Theophylline SANOFI AVENTIS US 89540

Drug Adverse Effects information for SLO-BID

Role code Indications Reaction # Reports
SS ASTHMA ANAEMIA 1
SS TYPE 2 DIABETES MELLITUS ANAEMIA 2
Ads by Google